Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Penack

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.
Haematologica|October 12, 2019
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working PartyOlaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Cancer Research|June 5, 2013
PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHDArnab Ghosh, Amanda M Holland, Yildirim Dogan, et al.
Frontiers in Neurology|February 6, 2026
The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicityLotta Völker, Leonie Müller-Jensen, Sophia Carl, et al.
Journal for Immunotherapy of Cancer|April 18, 2023
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working PartyOlaf Penack, Christophe Peczynski, Christian Koenecke, et al.
Stem Cells (Dayton, Ohio)|September 4, 2024
The global evolution and impact of systems biology and artificial intelligence in stem cell research and therapeutics development: a scoping reviewThayna Silva-Sousa, Júlia Nakanishi Usuda, Nada Al-Arawe, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation|December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseIl-Kang Na, Sydney X Lu, Nury L Yim, et al.
Rheumatology (Oxford, England)|February 10, 2025
Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritisFredrik N Albach, Ioanna Minopoulou, Artur Wilhelm, et al.
Stem Cells Translational Medicine|September 28, 2025
Artificial intelligence and systems biology analysis in stem cell research and therapeutics developmentThayna Silva-Sousa, Júlia Nakanishi Usuda, Nada Al-Arawe, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.
Haematologica|October 12, 2019
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working PartyOlaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Cancer Research|June 5, 2013
PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHDArnab Ghosh, Amanda M Holland, Yildirim Dogan, et al.
Frontiers in Neurology|February 6, 2026
The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicityLotta Völker, Leonie Müller-Jensen, Sophia Carl, et al.
Journal for Immunotherapy of Cancer|April 18, 2023
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working PartyOlaf Penack, Christophe Peczynski, Christian Koenecke, et al.
Stem Cells (Dayton, Ohio)|September 4, 2024
The global evolution and impact of systems biology and artificial intelligence in stem cell research and therapeutics development: a scoping reviewThayna Silva-Sousa, Júlia Nakanishi Usuda, Nada Al-Arawe, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation|December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseIl-Kang Na, Sydney X Lu, Nury L Yim, et al.
Rheumatology (Oxford, England)|February 10, 2025
Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritisFredrik N Albach, Ioanna Minopoulou, Artur Wilhelm, et al.
Stem Cells Translational Medicine|September 28, 2025
Artificial intelligence and systems biology analysis in stem cell research and therapeutics developmentThayna Silva-Sousa, Júlia Nakanishi Usuda, Nada Al-Arawe, et al.
Pageof 19